Phase II trial of LY 2624803 in patients with mild to moderate transient insomnia.

Trial Profile

Phase II trial of LY 2624803 in patients with mild to moderate transient insomnia.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Dec 2009

At a glance

  • Drugs LY 2624803 (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Hypnion
  • Most Recent Events

    • 18 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top